Why nominate? An interview with the 2019 BioAnalysis Rising Star award winner.

Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 6 of 6

Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 5 of 6

Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 4 of 6

Webinar | Introduction to Analytical Procedure (Method) Lifecycle Management

Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 3 of 6

Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 2 of 6

Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 1 of 6

WEBINAR | Improving Analytical Method Performance Through Quality Risk Management and a Design of Experiments Approach

High-throughput, Batch-processing Metabolite Identification

Improved Spectral Clarity with DIA Methods for Stuctural Elucidation Using CCS Values in Drug Discovery

Comprehensive, Data Compliant Metabolite Identification using the UNIFI Met ID Application

Using Collision Cross Section (CCS) Values to Identify and Track Metabolites in Drug Development

Taking Advantage of Ion Mobility Enabled Approaches for Discovery Metabolite Identification

High Resolution Mass Spectrometry for Quantification of Intact Monoclonal Antibodies in Plasma